000 01303 a2200349 4500
005 20250513100547.0
264 0 _c19961127
008 199611s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.1365-2125.1996.36916.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaylor, G W
245 0 0 _aExcursions in biomedical mass spectrometry.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cJul 1996
300 _a119-26 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Bacterial Agents
_xchemistry
650 0 4 _aCholesterol
_xbiosynthesis
650 0 4 _aChromatography, High Pressure Liquid
_xmethods
650 0 4 _aGas Chromatography-Mass Spectrometry
650 0 4 _aHelicobacter pylori
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMass Spectrometry
_xmethods
650 0 4 _aMevalonic Acid
_xmetabolism
650 0 4 _aMolecular Structure
650 0 4 _aPseudomonas aeruginosa
_xmetabolism
700 1 _aDonnelly, L E
700 1 _aMurray, S
700 1 _aRendell, N B
773 0 _tBritish journal of clinical pharmacology
_gvol. 42
_gno. 1
_gp. 119-26
856 4 0 _uhttps://doi.org/10.1046/j.1365-2125.1996.36916.x
_zAvailable from publisher's website
999 _c8801853
_d8801853